Short-cycle therapy in HIV-infected adults: rilpivirine combination 4 days on/3 days off therapy.
Dora LuiseEmanuela LattuadaSebastiano RizzardoStefano NicolèLorenza LambertenghiIlaria ColedanSilvia GambinoRossella GottardoMassimiliano LanzafameSandro VentoPublished in: The Journal of antimicrobial chemotherapy (2021)
SCT with rilpivirine-containing regimens could be an effective alternative to continuous therapy in selected HIV-infected patients with previous long-term virological suppression.